Related Experiment Video
Updated: Jun 6, 2026
07:01
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
Pheochromocytomas: the (pseudo)-hypoxia hypothesis.
Judith Favier1, Anne-Paule Gimenez-Roqueplo
1INSERM, U970, Paris Cardiovascular Research Center - PARCC, Paris, France. judith.favier@inserm.fr
Best Practice & Research. Clinical Endocrinology & Metabolism
|December 1, 2010
Summary
Chronic hypoxia is linked to neuroendocrine tumors like pheochromocytoma and paraganglioma. Genetic mutations affecting oxygen-sensing pathways activate hypoxia-inducible factors, driving tumor growth.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- A long-standing association exists between chronic hypoxia and increased incidence of head and neck paragangliomas.
- Discoveries in oxygen-sensing mechanisms and hereditary paraganglioma in the early 2000s confirmed a strong link between these neuroendocrine tumors and the hypoxic pathway.
Purpose of the Study:
- To elucidate the role of the hypoxic pathway in the tumorigenesis of pheochromocytoma and paraganglioma.
- To demonstrate how genetic mutations influence hypoxia-inducible factors and subsequent gene regulation in these tumors.
Main Methods:
- Review of physiological, genetic, cellular, and molecular data.
- Analysis of gene mutations (SDH and VHL) and their impact on hypoxia-inducible factors.
- Investigation of target gene regulation involved in tumor progression.
Main Results:
- Mutations in SDH and VHL genes lead to abnormal stabilization and activation of hypoxia-inducible factors.
- Activation of hypoxia-inducible factors results in the regulation of multiple target genes.
- These target genes are implicated in key processes such as proliferation, apoptosis, angiogenesis, metabolism, and metastasis.
Conclusions:
- The hypoxic or pseudohypoxic pathway plays a central role in the development of pheochromocytoma and paraganglioma.
- Genetic alterations affecting oxygen sensing are critical drivers of these neuroendocrine tumors.
- Understanding this pathway offers insights into tumor biology and potential therapeutic strategies.
Related Concept Videos
01:23Hypoxia
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:27Oxygen Transport in the Blood
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: